This series of bead-based multiplex detection kits for cytokines and chemokines meets the needs of researchers focusing on the areas of immunology, inflammation, and oncology. The kits, available over the next several months, will be solution-based, enabling simultaneous quantitative measurement (i.e., multiplexing) of up to 20 different proteins. Bead-based multiplexed assays will also give researchers a direct comparative measurement of multiple protein expression patterns (i.e., a biosignature) without the need for extrapolation among results from independent assays. Guava Technologies, Inc., 866-448-2827, www.guavatechnologies.com.